tiprankstipranks
Advertisement
Advertisement

CAMP Stock Latest News

Camp4 Therapeutics reports Q2 EPS (58c), consensus (21c)
The FlyCamp4 Therapeutics reports Q2 EPS (58c), consensus (21c)
8d ago
CAMP
Camp4 Therapeutics price target raised to $15 from $12 at Piper Sandler
PremiumThe Fly
Camp4 Therapeutics price target raised to $15 from $12 at Piper Sandler
8d ago
CAMP
CAMP4 Analyst Day, Strong Cash Runway and SYNGAP1 Trial Progress Drive Upward Price-Target Revision to $8 with Buy Rating
PremiumRatings
CAMP4 Analyst Day, Strong Cash Runway and SYNGAP1 Trial Progress Drive Upward Price-Target Revision to $8 with Buy Rating
9d ago
CAMP
CAMP Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CAMP Upcoming Earnings Report: What to Expect?
13d ago
CAMP
CAMP4 Therapeutics Secures $50 Million Private Financing
PremiumCompany Announcements
CAMP4 Therapeutics Secures $50 Million Private Financing
20d ago
8K
CAMP
CAMP4 gains Australian clearance, enabling CMP-002 trial and financing
PremiumCompany AnnouncementsCAMP4 gains Australian clearance, enabling CMP-002 trial and financing
28d ago
8K
CAMP
Camp4 Therapeutics receives Australia TGA clearance for CMP-002 trial
Premium
The Fly
Camp4 Therapeutics receives Australia TGA clearance for CMP-002 trial
28d ago
CAMP
X4 Pharmaceuticals appoints CAMP4 Therapeutics CFO Kelly Gold to board
Premium
The Fly
X4 Pharmaceuticals appoints CAMP4 Therapeutics CFO Kelly Gold to board
2M ago
CAMP
XFOR
Camp4 Therapeutics upgraded to Overweight from Neutral at JPMorgan
PremiumThe Fly
Camp4 Therapeutics upgraded to Overweight from Neutral at JPMorgan
2M ago
CAMP
CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan
PremiumCompany Announcements
CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan
2M ago
8K
CAMP
Camp4 Therapeutics initiated with a Buy at Chardan
PremiumThe Fly
Camp4 Therapeutics initiated with a Buy at Chardan
2M ago
CAMP
CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
PremiumCompany Announcements
CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
3M ago
8K
CAMP
Buy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028
PremiumRatingsBuy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028
4M ago
CAMP
Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c)
Premium
The Fly
Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c)
4M ago
CAMP
Camp4 Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Camp4 Therapeutics initiated with a Buy at Rodman & Renshaw
4M ago
CAMP
Camp4 Therapeutics price target raised to $9 from $8 at Leerink
PremiumThe Fly
Camp4 Therapeutics price target raised to $9 from $8 at Leerink
5M ago
CAMP
CAMP4 Therapeutics Adds Veteran CFO MacLean to Board
PremiumCompany Announcements
CAMP4 Therapeutics Adds Veteran CFO MacLean to Board
5M ago
8K
CAMP
CAMP Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CAMP Earnings this Week: How Will it Perform?
5M ago
CAMP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
CAMP
SPRB
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
6M ago
CAMP
CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress
Premium
Company Announcements
CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress
6M ago
8K
CAMP
Camp4 Therapeutics participates in a conf call hosted by Cantor Fitzgerald
Premium
The Fly
Camp4 Therapeutics participates in a conf call hosted by Cantor Fitzgerald
6M ago
CAMP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >